Metraipolis › archive › dc_04cee0925a99

Safety and immunogenicity of 13-Valent pneumococcal conjugate vaccine in healthy infants in Shanghai during the COVID-19 pandemic: a prospective cohort study — Europe PMC PMID:41939903

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41939903
DOI
10.3389/fimmu.2026.1766313
License (as archived)
solo-consultazione
Archived
2026-11-04T04:40:49.991Z
SHA-256 of the archived text
1dc61eb543e6b36021ebfcca64cfeabeacec9cab4134fb34226108ca1d07ec84
Stable URL of this page
https://metraipolis.com/documento/dc_04cee0925a99

How to cite

Safety and immunogenicity of 13-Valent pneumococcal conjugate vaccine in healthy infants in Shanghai during the COVID-19 pandemic: a prospective cohort study — Europe PMC PMID:41939903 — Europe PMC (en), https://europepmc.org/article/MED/41939903 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_04cee0925a99 (Metraipolis archive dc_04cee0925a99, sha256 1dc61eb543e6b36021ebfcca64cfeabeacec9cab4134fb34226108ca1d07ec84)
BibTeX
@misc{dc04cee0925a99,
  title = {Safety and immunogenicity of 13-Valent pneumococcal conjugate vaccine in healthy infants in Shanghai during the COVID-19 pandemic: a prospective cohort study — Europe PMC PMID:41939903},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41939903},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_04cee0925a99; sha256 1dc61eb543e6b36021ebfcca64cfeabeacec9cab4134fb34226108ca1d07ec84},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41939903. Agents can read the archived copy with the MCP tool read_document.